- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05687643
Shear Load In-shoe Plantar Sensing/Strain Analyses and Mapping in Diabetic Foot Ulcers (SLIPSTREAM)
Study Overview
Status
Conditions
Detailed Description
Stain Analysis Mapping of the Plantar surface (STAMP) is a method designed by the University of Leeds to measure 'in-shoe' strain patterns on the plantar surface of the foot. The insole comprises a pseudorandom pattern applied to a plastically deformable insole using a temporary tattoo layer. STAMP utilises digital image correlation to track the deformation of the pattern following a period of walking.
Shear Load Inductive Plantar Sensing (SLIPS) is an insole designed by the University of Leeds to measure plantar shear stress and plantar pressure. SLIPS is an insole which integrates 64 tri-axis soft force sensors which simultaneously measures shear stress and pressure. The SLIPS insole has been designed to measure the plantar load of the right foot and due to its size can only be accommodated by a size 8-11 shoe.
The commercial device Pedar (Novel gmbh) will be used as a reference for plantar pressure measurement in both groups.
This study aims to compare plantar strain using STAMP and plantar shear stress and plantar pressure using SLIPS in two groups of patients with diabetes; high risk patients with a recently healed plantar ulcer and low risk patients (according to the NICE definition).
It is hypothesised that patients with a recently healed plantar ulcer with exhibit elevated plantar strain, plantar shear stress and plantar pressure than the low risk group.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
West Yorkshire
-
Leeds, West Yorkshire, United Kingdom, LS9 7TF
- Leeds Teaching Hospitals NHS Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
DFU group:
Patients with a recently healed plantar ulcer recruited from a specialised Diabetes Limb Salvage Service in a tertiary referral centre.
Low risk group:
Patients with diabetes and low risk for ulceration recruited from the community podiatry service.
Description
DFU group:
Patients will undergo STAMP and Pedar assessment if they fulfil the following criteria.
Inclusion Criteria:
- Age >18
- A diagnosis of diabetes mellitus
- A diagnosis of diabetic peripheral neuropathy
- Recently healed plantar ulcer (within the last 3 months)
- Able to provide informed consent
- Previous open or endovascular revascularisation
SLIPS inclusion criteria:
Patients will also undergo assessment with the SLIPS insole if they fulfil the following inclusion criteria:
- Recently healed plantar DFU located on the right foot
- The right foot can be accommodated in a size 8-11 shoe
- Weight <100kg
Low risk group:
Patients will undergo STAMP and Pedar assessment if they fulfil the following criteria:
- Age >18
- A diagnosis of diabetes mellitus
- Low risk for DFU according to the NICE NG 19 guidelines (no risk factors for ulceration except callus alone)
- Able to provide informed consent
Exclusion Criteria:
- Unable to mobilise independently 150m without the use of walking aids and thus unable to complete the walking assessments
- Previous ipsilateral minor amputation
- Previous ipsilateral surgical offloading procedure
- Previous contralateral major amputation
- Ipsilateral toe pressure <40mmHg
SLIPS assessment inclusion:
- The right foot can be accommodated in a size 8-11 shoe
- Weight <100kg
Exclusion criteria:
- Unable to mobilise independently 150m without the use of walking aids and thus unable to complete the walking assessments
- Previous ipsilateral minor amputation
- Presence of a foot deformity
- Previous contralateral major amputation
- Ipsilateral toe pressure <40mmHg
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Diabetic Foot Ulcer (DFU) group
Inclusion criteria:
|
|
Low risk group
Inclusion criteria:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak plantar strain
Time Frame: At clinical visit on study entry
|
The difference in peak plantar strain (%) (as measured with STAMP) between the DFU and low risk group
|
At clinical visit on study entry
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Regional peak plantar strain
Time Frame: At clinical visit on study entry
|
The difference in regional peak plantar strain (%) between the DFU and low risk group at the 10 pre-specified regions: heel, midfoot, 1st metatarsal head (MTH), 2nd MTH, 3rd MTH, 4th MTH, 5th MTH, hallux, 2nd toe, toes 3-5
|
At clinical visit on study entry
|
|
Regional peak plantar shear
Time Frame: At clinical visit on study entry
|
The difference in regional peak plantar shear (kPa) between the DFU and low risk group at the 10 pre-specified regions: heel, midfoot, 1st metatarsal head (MTH), 2nd MTH, 3rd MTH, 4th MTH, 5th MTH, hallux, 2nd toe, toes 3-5
|
At clinical visit on study entry
|
|
Peak Plantar pressure
Time Frame: At clinical visit on study entry
|
Global peak plantar pressure (kPa) between DFU and low risk groups.
|
At clinical visit on study entry
|
|
Regional Peak Plantar pressure
Time Frame: At clinical visit on study entry
|
Regional peak plantar pressure (kPa) between DFU and low risk groups
|
At clinical visit on study entry
|
Collaborators and Investigators
Investigators
- Principal Investigator: David A Russell, University of Leeds
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VS21/143856
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Foot
-
PolarityTETemporarily not availableNeuropathic Diabetic Ulcer - Foot | Diabetic Foot Disease | DFU
-
DEBx Medical B.V.Not yet recruitingDiabetic Foot Wounds | Diabetic Foot Ulcer (DFU) | Diabetic Foot Ulcer Treatment
-
Başakşehir Çam & Sakura City HospitalRecruitingDiabetic Foot Infection | Diabetic Amputation Foot Wound | Diabetic Foot DiseaseTurkey (Türkiye)
-
StimLabsNot yet recruitingDiabetic Foot | Foot Ulcer | Ulcer Foot | Diabetic Foot Ulcer (DFU)
-
Applied Biologics, LLCSerena GroupRecruitingUlcer | Diabetic Foot Ulcer | Diabetic Foot Ulcers (DFU) | Foot Ulcer ChronicUnited States
-
Ege UniversityNot yet recruitingVirtual Reality | Diabetic | Foot Care | Diabetic Foot - Telemedical Monitoring
-
Cairo UniversityNot yet recruitingDiabetic Foot UlcerEgypt
-
Omeza, LLCSygNola, LLCRecruitingDiabetic Foot UlcerUnited States
-
Universidad Autonoma de Nuevo LeonCompleted
-
Lo Zhiwen JosephOtivio ASRecruitingDiabetic Foot UlcerSingapore